0G8X.LImmunovia AB

About

Immunovia AB (publ), a diagnostic company, develops blood diagnostic for detecting pancreatic cancer in Sweden. It also focuses on the development and commercialization of blood-based testing to detect proteins and antibodies that indicate pancreatic cancer in an individual. Immunovia AB (publ) was incorporated in 2007 and is headquartered in Lund, Sweden.

www.immunovia.com

Key Statistics

Market Cap

66.38M

EPS

-0.42

Dividend Yield

0.00%

Beta

2.68

P/B

1.21

Return on Equity

-225.4%

Sector

Healthcare

Industry

Medical - Pharmaceuticals

CEO

Jeff Borcherding

Employees

13

IPO Date

2018-01-26

Country

SE